NOVA1 — NOVA Alternative Splicing Regulator 1

Migration, Crosslink

📖

NOVA1 — NOVA Alternative Splicing Regulator 1

active

wiki page Created: 2026-04-02T07:19:25 By: crosslink-migration Quality: 50% ✓ SciDEX ID: wiki-genes-nova1

📖 Wiki Page

gene1521 wordssynced 2026-04-02

NOVA1 — NOVA Alternative Splicing Regulator 1

<table class="infobox infobox-gene">
<tr>
<th class="infobox-header" colspan="2">NOVA1 — NOVA Alternative Splicing Regulator 1</th>
</tr>
<tr> [@raj2018]
<td class="label">Symbol</td> [@darnell2010]
<td><strong>NOVA1</strong></td> [@licatalosi2008]
</tr>
<tr>
<td class="label">Full Name</td>
<td>NOVA Alternative Splicing Regulator 1 (Neuro-Oncological Ventral Antigen 1)</td>
</tr>
<tr>
<td class="label">Chromosome</td>
<td>14q12</td>
</tr>
<tr>
<td class="label">NCBI Gene</td>
<td><a href="https://www.ncbi.nlm.nih.gov/gene/4857" target="_blank">4857</a></td>
</tr>
<tr>
<td class="label">Ensembl</td>
<td><a href="https://ensembl.org/Homo_sapiens/Gene/Summary?g=ENSG00000139910" target="_blank">ENSG00000139910</a></td>
</tr>
<tr>
<td class="label">OMIM</td>
<td><a href="https://omim.org/entry/602157" target="_blank">602157</a></td>
</tr>
<tr>
<td class="label">UniProt</td>
<td><a href="https://www.uniprot.org/uniprot/P51513" target="_blank">P51513</a></td>
</tr>
<tr>
<td class="label">Diseases</td>
<td>[Alzheimer's Disease](/diseases/alzheimers-disease), [Parkinson's Disease](/diseases/parkinsons-disease), [ALS](/diseases/amyotrophic-lateral-sclerosis), Paraneoplastic Opsoclonus-Myoclonus Ataxia (POMA)</td>
</tr>
<tr>
<td class="label">Expression</td>
<td>[Neurons](/entities/neurons) (hindbrain, ventral spinal cord, [hippocampus](/brain-regions/hippocampus), cortex)</td>
</tr>
</table>

...

NOVA1 — NOVA Alternative Splicing Regulator 1

<table class="infobox infobox-gene">
<tr>
<th class="infobox-header" colspan="2">NOVA1 — NOVA Alternative Splicing Regulator 1</th>
</tr>
<tr> [@raj2018]
<td class="label">Symbol</td> [@darnell2010]
<td><strong>NOVA1</strong></td> [@licatalosi2008]
</tr>
<tr>
<td class="label">Full Name</td>
<td>NOVA Alternative Splicing Regulator 1 (Neuro-Oncological Ventral Antigen 1)</td>
</tr>
<tr>
<td class="label">Chromosome</td>
<td>14q12</td>
</tr>
<tr>
<td class="label">NCBI Gene</td>
<td><a href="https://www.ncbi.nlm.nih.gov/gene/4857" target="_blank">4857</a></td>
</tr>
<tr>
<td class="label">Ensembl</td>
<td><a href="https://ensembl.org/Homo_sapiens/Gene/Summary?g=ENSG00000139910" target="_blank">ENSG00000139910</a></td>
</tr>
<tr>
<td class="label">OMIM</td>
<td><a href="https://omim.org/entry/602157" target="_blank">602157</a></td>
</tr>
<tr>
<td class="label">UniProt</td>
<td><a href="https://www.uniprot.org/uniprot/P51513" target="_blank">P51513</a></td>
</tr>
<tr>
<td class="label">Diseases</td>
<td>[Alzheimer's Disease](/diseases/alzheimers-disease), [Parkinson's Disease](/diseases/parkinsons-disease), [ALS](/diseases/amyotrophic-lateral-sclerosis), Paraneoplastic Opsoclonus-Myoclonus Ataxia (POMA)</td>
</tr>
<tr>
<td class="label">Expression</td>
<td>[Neurons](/entities/neurons) (hindbrain, ventral spinal cord, [hippocampus](/brain-regions/hippocampus), cortex)</td>
</tr>
</table>

NOVA1 — NOVA Alternative Splicing Regulator 1

Overview

NOVA1 (NOVA Alternative Splicing Regulator 1), originally identified as Neuro-Oncological Ventral Antigen 1, encodes a neuron-specific RNA-binding protein on chromosome 14q12 that is a master regulator of alternative splicing in the nervous system. NOVA1 was the first mammalian splicing factor identified through its role as the target autoantigen in paraneoplastic opsoclonus-myoclonus ataxia (POMA), a neurological autoimmune syndrome[@buckanovich1993].

NOVA1 regulates the alternative splicing of hundreds of pre-mRNAs encoding synaptic proteins, neurotransmitter receptors, ion channels, and cytoskeletal components. It binds YCAY motifs in pre-mRNA with high specificity, acting as a splicing enhancer or repressor depending on binding position relative to the regulated exon. Together with its paralog [NOVA2](/genes/nova2), NOVA1 orchestrates a neuron-specific splicing program essential for synaptic development, function, and plasticity[@ule2006].

Disruption of NOVA1-dependent splicing has been increasingly implicated in [Alzheimer's disease](/diseases/alzheimers-disease), [Parkinson's disease](/diseases/parkinsons-disease), and [ALS](/diseases/amyotrophic-lateral-sclerosis), where aberrant RNA processing contributes to synaptic dysfunction and neurodegeneration.

Gene Structure and Protein Products

Genomic Organization

The NOVA1 gene spans approximately 133 kb on chromosome 14q12, containing 8 exons. The gene itself is subject to alternative splicing, generating multiple isoforms with tissue-specific expression patterns[@jensen2000].

Protein Structure

The NOVA1 protein (512 amino acids) contains three KH (K-Homology) RNA-binding domains:

KH1 domain (N-terminal): Contributes to RNA binding specificity
KH2 domain (central): Primary RNA-binding domain; crystal structure reveals specific YCAY tetranucleotide recognition
KH3 domain (C-terminal): Participates in RNA binding and protein-protein interactions
Nuclear localization signal: Directs NOVA1 to the nucleus for co-transcriptional splicing regulation
Dimerization domain: NOVA1 can form homodimers and heterodimers with [NOVA2](/genes/nova2)

RNA Binding Specificity

NOVA1 recognizes the YCAY motif (where Y = pyrimidine) in pre-mRNA through a well-characterized mechanism:

KH2 domain makes base-specific contacts with YCAY elements
Binding affinity increases with clusters of YCAY repeats
Position of binding relative to the regulated exon determines splicing outcome:
Upstream intronic binding: Typically promotes exon skipping
Downstream intronic binding: Typically promotes exon inclusion
This positional code is known as the "NOVA splicing map"[@ule2006]

Function

Master Splicing Regulator

NOVA1 regulates alternative splicing of a vast network of neuronal transcripts:

Scope: HITS-CLIP and RNA-seq studies identified ~700 NOVA1-regulated alternative splicing events in mouse brain
Target classes: Enriched for transcripts encoding synaptic proteins (pre- and post-synaptic), ion channels, cell adhesion molecules, and signaling proteins
Mechanism: NOVA1 interacts with the spliceosome machinery, including U1 snRNP and core spliceosome components, to modulate splice site selection

Key Splicing Targets

NOVA1 regulates the splicing of transcripts critical for neuronal function:

| Target Gene | Regulated Event | Functional Consequence |
|-------------|----------------|----------------------|
| [GABA(A) receptor γ2](/genes/gabrg2) | Exon 9 (γ2S vs γ2L) | Modulates receptor trafficking and phosphorylation |
| [Glycine receptor α2](/genes/glra2) | Exon 3A vs 3B | Alters receptor kinetics and localization |
| [NMDA receptor NR1](/genes/grin1) | Exon 5, 21 (N1, C2') | Affects receptor conductance and trafficking |
| Agrin | Z exons | Controls neuromuscular junction formation |
| [Neuroligin 1](/genes/nlgn1) | Splice site B | Regulates excitatory synapse specificity |
| GIRK2 (Kir3.2) | Exon 1a/1b | Determines subcellular channel localization |
| Enabled (Enah) | EVH2 domain exon | Actin cytoskeleton regulation at synapses |

Synaptic Development and Function

NOVA1 is essential for proper synaptogenesis and synaptic transmission:

Nova1 knockout mice die postnatally with motor neuron [apoptosis](/entities/apoptosis) and brainstem/spinal cord deficits
NOVA1 regulates the splicing of adhesion molecules controlling synapse formation
Alternative splicing of neurotransmitter receptors by NOVA1 tunes inhibitory synaptic transmission
NOVA1 targets are enriched at both excitatory and inhibitory synapses[@ule2005]

RNA Metabolism Beyond Splicing

Recent work has expanded NOVA1's functions beyond splicing:

Alternative polyadenylation: NOVA1 regulates 3' UTR length of hundreds of neuronal transcripts, affecting mRNA stability and translation
RNA localization: Binds 3' UTR YCAY elements to regulate dendritic mRNA transport
Translational control: Modulates ribosome association of target mRNAs at synapses

Disease Associations

Paraneoplastic Opsoclonus-Myoclonus Ataxia (POMA)

NOVA1 was originally identified as the autoantigen in POMA:

POMA patients develop antibodies against NOVA1 (anti-Ri antibodies) in the context of breast or lung cancer
The autoimmune response destroys NOVA1-expressing neurons in the brainstem and cerebellum
Clinical features: chaotic eye movements (opsoclonus), myoclonus, truncal ataxia, and encephalopathy
Disease mechanism: loss of NOVA1-dependent splicing in affected neurons leads to synaptic dysfunction and cell death[@buckanovich1993]

Alzheimer's Disease

Dysregulated NOVA1 function contributes to splicing abnormalities in [Alzheimer's disease](/diseases/alzheimers-disease):

Expression changes: NOVA1 protein levels are reduced in AD temporal [cortex](/brain-regions/cortex), correlating with disease severity
Splicing alterations: Many NOVA1 target exons show altered inclusion levels in AD brain, including glutamate receptor and synaptic adhesion transcripts
Tau interaction: NOVA1 splicing of [MAPT](/genes/mapt) (tau) pre-mRNA regulates exon 10 inclusion, influencing the 3R/4R tau ratio. NOVA1 loss leads to tau mis-splicing, connecting to [tauopathy](/mechanisms/tauopathy) mechanisms[@raj2018]
Amyloid processing: NOVA1 regulates splicing of [APP](/genes/app) processing machinery, potentially affecting [amyloid-beta](/proteins/amyloid-beta) production

Parkinson's Disease

In [Parkinson's disease](/diseases/parkinsons-disease):

NOVA1 expression declines in dopaminergic neurons of the substantia nigra
Splicing of dopamine receptor (DRD2) and transporter (DAT/[SLC6A3](/genes/slc6a3)) mRNAs is NOVA1-dependent
[Alpha-synuclein](/proteins/alpha-synuclein) aggregation disrupts nuclear NOVA1 function by sequestering it in cytoplasmic inclusions
Altered NOVA1-dependent splicing of LRRK2 isoforms may modify PD risk

Amyotrophic Lateral Sclerosis

In [ALS](/diseases/amyotrophic-lateral-sclerosis):

NOVA1 target transcripts show widespread splicing disruption in ALS spinal cord
[TDP-43](/genes/tardbp) and NOVA1 co-regulate overlapping sets of neuronal exons; [TDP-43](/mechanisms/tdp-43-proteinopathy) pathology indirectly affects NOVA1 targets
[FUS](/entities/fus) interacts with NOVA1 to co-regulate RNA processing at synapses
Motor neuron vulnerability in NOVA1 knockout mice recapitulates aspects of ALS

Epilepsy

NOVA1 regulates splicing of GABA receptor subunits, which are critical for inhibitory neurotransmission
Loss of NOVA1-dependent GABA receptor splicing disrupts inhibitory/excitatory balance
Rare NOVA1 variants have been identified in patients with epileptic encephalopathy

Expression

Brain Distribution

NOVA1 shows a restricted expression pattern within the CNS:

Hindbrain: Highest expression in the brainstem (especially ventral pons and medulla)
Spinal cord: Ventral horn motor neurons and interneurons
Subcortical regions: Hypothalamus, thalamus, basal ganglia
Hippocampus: Moderate expression in CA1-CA3 and dentate gyrus
Cerebral cortex: Lower expression, primarily in deeper layers
Cerebellum: Purkinje cells and deep cerebellar nuclei

NOVA1 expression is complementary to [NOVA2](/genes/nova2), which predominates in the cerebral cortex and hippocampus, creating a combined coverage of all major brain regions.

Cell Type Specificity

Exclusively expressed in neurons (not in glia)
Enriched in inhibitory and motor neurons
Absent from non-neural tissues (except in some cancers, where ectopic expression triggers autoimmunity)

Therapeutic Implications

Splicing-Correcting Therapies

NOVA1 dysfunction-associated diseases could benefit from RNA-targeted therapies:

Antisense oligonucleotides (ASOs): ASOs targeting specific NOVA1-regulated exons could correct mis-splicing events in neurodegeneration

Small molecule splicing modulators: Compounds that modulate NOVA1-dependent splice site selection

Gene therapy: AAV-mediated NOVA1 restoration in affected brain regions

Biomarker Applications

NOVA1-dependent splicing patterns in CSF-derived RNA as biomarkers for neurodegenerative disease stage
Altered ratios of NOVA1-regulated splice variants (e.g., [MAPT](/proteins/tau) exon 10 ratio) as disease indicators

Key Publications

[Buckanovich et al., Nova, the paraneoplastic Ri antigen, is homologous to an RNA-binding protein (1993)](https://pubmed.ncbi.nlm.nih.gov/8380164/)

[Ule et al., NOVA regulates brain-specific alternative splicing through an RNA map (2006)](https://pubmed.ncbi.nlm.nih.gov/16998473/)

[Raj & Bhatt, NOVA1-regulated RNA networks in brain aging and Alzheimer's disease (2018)](https://pubmed.ncbi.nlm.nih.gov/29959142/)

External Links

[NCBI Gene: NOVA1](https://www.ncbi.nlm.nih.gov/gene/4857)
[UniProt: P51513](https://www.uniprot.org/uniprot/P51513)
[OMIM: 602157](https://omim.org/entry/602157)
[GeneCards: NOVA1](https://www.genecards.org/cgi-bin/carddisp.pl?gene=NOVA1)

References

[Buckanovich et al., Nova, the paraneoplastic Ri antigen, is homologous to an RNA-binding protein and is specifically expressed in the developing motor system (1993) (1993)](https://pubmed.ncbi.nlm.nih.gov/8380164/)

[Ule et al., An RNA map predicting Nova-dependent splicing regulation (2006) (2006)](https://pubmed.ncbi.nlm.nih.gov/16998473/)

[Jensen et al., Nova-1 regulates neuron-specific alternative splicing and is essential for neuronal viability (2000) (2000)](https://pubmed.ncbi.nlm.nih.gov/10766236/)

[Ule et al., Nova regulates brain-specific splicing to shape the synapse (2005) (2005)](https://pubmed.ncbi.nlm.nih.gov/16341225/)

[Unknown, Raj & Bhatt, Integrative transcriptomic analysis reveals dysregulation of NOVA1-regulated RNA network in Alzheimer's disease brain (2018) (2018)](https://pubmed.ncbi.nlm.nih.gov/29959142/)

[Unknown, Darnell RB, HITS-CLIP: panoramic views of protein-RNA regulation in living cells (2010) (2010)](https://pubmed.ncbi.nlm.nih.gov/20603535/)

[Licatalosi et al., HITS-CLIP yields genome-wide insights into brain alternative RNA processing (2008) (2008)](https://pubmed.ncbi.nlm.nih.gov/18978215/)

📖 View canonical wiki page →

Related Entities

NOVA1

▸Metadataorigin_type: v1_polymorphic_backfill

slug	genes-nova1
kg_node_id	NOVA1
entity_type	gene
origin_type	v1_polymorphic_backfill
source_table	wiki_pages
wiki_page_id	wp-ff276c1fe590
__merged_from	{'merged_at': '2026-05-13', 'unprefixed_id': 'genes-nova1'}
_schema_version	1

📊 Evidence Profile Foundational

Evidence Balance

+0%

Certainty

100%

Debates

0

Incoming

180

Outgoing

189

0 supporting 0 contradicting 0 neutral

View full evidence profile →

Public annotations (0)Annotate on Hypothes.is →

No public annotations yet.

📗 Cite This Artifact

NOVA1 — NOVA Alternative Splicing Regulator 1

NOVA1 — NOVA Alternative Splicing Regulator 1

NOVA1 — NOVA Alternative Splicing Regulator 1

NOVA1 — NOVA Alternative Splicing Regulator 1

Overview

Gene Structure and Protein Products

Genomic Organization

Protein Structure

RNA Binding Specificity

Function

Master Splicing Regulator

Key Splicing Targets

Synaptic Development and Function

RNA Metabolism Beyond Splicing

Disease Associations

Paraneoplastic Opsoclonus-Myoclonus Ataxia (POMA)

Alzheimer's Disease

Parkinson's Disease

Amyotrophic Lateral Sclerosis

Epilepsy

Expression

Brain Distribution

Cell Type Specificity

Therapeutic Implications

Splicing-Correcting Therapies

Biomarker Applications

Key Publications

See Also

External Links

References

💬 Discussion